Chemistry & Life Science Business Headlines

Andrew M Smith andrew at selectscience.net
Fri Apr 9 05:12:52 EST 1999


This week, www.selectscience.net reported on 28 news stories the day they
happened, so if you need to keep up to speed on the latest business
developments in chemistry and life science, make www.selectscience.net part
of your daily routine.

Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net

This week's headlines were:

Rheometric Scientific Reports Improvement in 1998 Results

Molecular Applications Group and Monsanto Company Sign Discovery Partnership
Agreement On Prediction of Gene and Protein Function

Stanford Announce Novel Gene Therapy Approach for Cystic Fibrosis

Genentech Discussing HCG Settlement With U.S. Government

Neurocrine Announces Successful Completion of Phase Ib Insomnia Trial

Biogen Reports Record First Quarter 1999 Results

Genset Achieves a Significant Milestone in Its Prostate Cancer Alliance with
Synthélabo

Quark Biotech Signs $19 Million Stroke Gene Agreement With Fujisawa
Pharmaceutical

Biotech Industry Adopts Statement Opposing Discriminatory Misuse Of Medical
Information

DIANON Systems, Inc. Signs Definitive Agreement to Acquire Assets of Kyto
Meridien Diagnostics, LLC

Molecular Innovations, Inc. Receives SBIR Phase I Grant to Develop a Nucleic
Acid-Based Test for the Food Pathogen, Listeria

New Chairman for Nycomed Amersham

Updated Medical Device Industry Releases Legislative Proposals to Expedite
Innovative Products into the Medicare System

Biotech Industry Adopts Statement Opposing Discriminatory Misuse Of Medical
Information

Dow AgroSciences & Integrated Genomics Announce Research and Licensing
Agreement

Molecular Probes Grants Cellomics Exclusive License to Key Fluorescence
Technologies for High Content Screening

Curative Health Services Receives Subpoena

Extended Regulatory Approval for Celsis Technology

Bio-Rad Laboratories Acquires Patent Portfolio For Hereditary
Hemochromatosis Gene

Abbott Reports Increase in Sales, Earnings in First Quarter

Aurora Biosciences Extends Ion Channel Technology Platform with Exclusive
License to Cell Membrane Potential Measurement Technique

BIO Response to NBAC on Stem Cell Research

Pharmacia & Upjohn and Versicor Collaborate On New Oxazolidinone
Antibacterials

Astra and Zeneca Complete Merger

Genzyme Tissue Repair Announces Proposed Terms For Transfer of its NeuroCell
Program to Genzyme General

Cubist Pharmaceuticals Releases 1998 Annual Report Electronically

Rohm And Haas Extends Morton Tender offer To April 16, 1999

Waters Issued Patent Issued for Novel Solid-Phase Extraction Sorbent
Technology

Karin Eastham Resigns as Vice President, Finance and Administration and
Chief Financial Officer of CombiChem

Delsys Forms Collaboration with The  R.W. Johnson Pharmaceutical Research
Institute to Develop New Technology for Drug Delivery

GPC AG and Evotec Biosystems AG Enter Drug Discovery Alliance for Novel
Genomics-Derived Antibacterial Target

Idun Appoints John J. Serbin, Ph.D. as Vice President, Corporate Development

Nanogen Advances SNP Identification Technology

US FDA Approves First Biologic Therapy for Clotting Disorder






More information about the Bioforum mailing list